Answers

What does "pathogenic variant" mean on a genetic report?

One word on a genetic report can carry a lot of weight. It names a DNA change and a condition, and leaves open how sure the lab is and whether the condition ever shows up.

Arun Verma, co-founder of Triangle · 2026-10-19

This is not clinical evidence and not medical advice. It does not replace your care team. Discuss anything here with your clinician before you act on it.

What does "pathogenic variant" mean on a genetic report?

It means the lab judged, from the research to date, that a change in your DNA is responsible for causing a particular condition. On MedlinePlus Genetics' scale, pathogenic is the end where there is ample scientific research linking the variant to the disease. Lab standards from two professional groups, ACMG and AMP, ask that every pathogenic call be reported with a named condition and inheritance pattern. The label describes the variant, not a sure outcome for a person. NHGRI's glossary says a pathogenic variant may increase a person's risk of a condition, and that in many cases carrying one does not guarantee the condition will develop. Pathogenic variants can be inherited from a parent or can arise on their own, from factors such as environmental exposure and aging. A variant that is pathogenic for one disease is not necessarily pathogenic for another, MedlinePlus adds.

Where do "pathogenic" and "likely pathogenic" sit among the result categories?

At the disease-causing end of a five-step scale. A 2015 joint recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP) recommended the terms pathogenic, likely pathogenic, uncertain significance, likely benign and benign for variants in Mendelian disorders. The middle step, uncertain significance, means the variant cannot yet be confirmed to play a role in disease. The same paper recommends retiring the words "mutation" and "polymorphism", because they led to wrong assumptions about whether a change was harmful or harmless, and using "variant" with one of the five labels instead. NSGC notes that results are often stated in various ways: positive, high risk, pathogenic, inconclusive, variants or mutations.

What is the difference between "pathogenic" and "likely pathogenic"?

How sure the lab is. MedlinePlus describes a likely pathogenic variant as probably responsible for causing disease, without enough scientific research to be certain. ACMG and AMP proposed that "likely" mean greater than 90% certainty that a variant is disease-causing, a common definition they call arbitrary, and noted that most variants do not have the data for an exact figure. In practice the two are often handled alike. A toolkit for non-genetics clinicians from the NIH-funded CSER Consortium, hosted by NHGRI, says pathogenic and likely pathogenic variants are usually treated the same clinically, as if they are likely disease causing.

Does a pathogenic variant mean the condition will happen?

Not necessarily. The key idea is penetrance. MedlinePlus Genetics defines it as the proportion of people with a particular variant who show signs and symptoms of a genetic disorder, and calls it reduced, or incomplete, when some people with the variant do not develop features. It says this probably comes from a mix of genetic, environmental and lifestyle factors, many of them unknown. Among people who do develop a condition, the signs can differ. MedlinePlus calls this variable expressivity: the range of signs and symptoms in different people with the same genetic condition. Why a person was tested matters too. The ACMG/AMP paper says the penetrance of a pathogenic variant found in someone without symptoms or a family history may be far less than estimates drawn from people tested because they had the disease.

What does "germline" or "inherited" mean next to a pathogenic variant?

It means the variant is in the DNA you were born with. MedlinePlus Genetics says inherited variants pass from parent to child, are present in virtually every cell, and are called germline variants because they are present in the parent's egg or sperm cells. Somatic variants arise later, sit only in certain cells and cannot be passed on. Because relatives share some genetic material, a positive result may also have implications for certain blood relatives. A study published October 8, 2026, in Cancer Discovery looked at how often pathogenic germline variants turn up in people already diagnosed with cancer. Researchers at Memorial Sloan Kettering sequenced inherited DNA from 39,184 people with solid tumors, checking more than 90 genes linked to inherited cancer risk. They found pathogenic variants in 18.4% of people whose cancer was diagnosed early for its type, 15.6% of those diagnosed around the usual age and 12.3% of those diagnosed later.

Can a pathogenic result change or be wrong?

It can, though pathogenic is meant to be a firm call. The ACMG/AMP paper calls pathogenic and benign near definitive classifications and encourages labs to consider proactively amending a report when one of them has to be reclassified. MedlinePlus says variants should be re-evaluated periodically, because a classification can change as research adds information. Two questions sit inside every result: is the variant really there, and what does it mean. The CSER toolkit says it is highly likely a reported variant is truly present, especially if the lab confirmed it with a second method such as Sanger sequencing, but that a pathogenic or likely pathogenic label may be incorrect and new evidence can lead to reclassification. ACMG and AMP recommend confirming pathogenic and likely pathogenic findings with a second, independent method, except in noted cases.

What if "pathogenic" shows up on a consumer DNA test?

It is usually a starting point that needs checking, not a clinical finding. Because standards can differ, MedlinePlus Genetics says consumer results typically need to be confirmed by additional testing ordered through a healthcare provider before they can be considered diagnostic. NSGC describes at-home tests as typically more limited than clinical testing and says they don't follow the same guidelines. Consumer tests also differ from one another. The FDA says not all consumer genetic test companies test for the same set of variants, so they may give different results for the same condition, and that genetic health risk tests do not determine a person's overall risk. The ACMG/AMP paper adds that "pathogenic" and "likely pathogenic" are not the right labels for risk alleles in common complex disorders, which it suggests reporting as risk alleles instead.

Where does a genetic counselor fit, and what could I ask?

A genetic counselor is the person who can put the label in context. NHGRI's glossary says a genetic counselor might provide information about how a genetic condition could affect an individual or family, and interpret genetic tests designed to help estimate the risk of a disease. MedlinePlus points to the NSGC's searchable directory of genetic counselors in the United States and Canada. A few fair questions: which condition and inheritance pattern the lab named, whether the variant is pathogenic or likely pathogenic and what evidence put it there, whether it was confirmed with a second method, and whether the lab would send an amended report if the label changed. You could also ask what the report says about penetrance; the ACMG/AMP paper says a discussion of decreased penetrance and variable expressivity, if relevant, belongs in the final report. Providers weigh medical history, family history and the type of test when they interpret results, so another question is which of those were taken into account. No source says what a pathogenic label means for one specific person; that takes someone who knows your history and the full report.

Sources

• MedlinePlus Genetics: Do all gene variants affect health and development?: MedlinePlus Genetics says a variant is evaluated using scientific research to date and classified on a spectrum based on how likely it is to lead to the disorder, and that a pathogenic variant is responsible for causing disease, with ample scientific research to support an association between the disease and the variant.
• Richards et al., ACMG/AMP Standards and Guidelines for the Interpretation of Sequence Variants, Genet Med 2015;17(5):405-424 (PMC4544753) (Terminology): ACMG/AMP recommend that all assertions of pathogenicity, including likely pathogenic, be reported with respect to a condition and inheritance pattern.
• NHGRI Talking Glossary: Pathogenic Variant: NHGRI's glossary says a pathogenic variant is a genomic variant that may increase a person's risk of developing a condition, disorder or disease, and that in many cases carrying one does not guarantee that a person will develop the specific condition but increases the risk for it.
• NHGRI Talking Glossary: Pathogenic Variant: NHGRI's glossary says pathogenic variants can be inherited from a parent or can occur spontaneously due to factors such as environmental exposure and aging.
• MedlinePlus Genetics: Do all gene variants affect health and development?: MedlinePlus Genetics says a variant that is pathogenic for one disease is not necessarily pathogenic for a different disease.
• Richards et al., ACMG/AMP Standards and Guidelines for the Interpretation of Sequence Variants, Genet Med 2015;17(5):405-424 (PMC4544753) (Introduction): The ACMG/AMP report, from a workgroup of ACMG, AMP and CAP, recommends the standard terms pathogenic, likely pathogenic, uncertain significance, likely benign and benign to describe variants identified in Mendelian disorders.
• MedlinePlus Genetics: Do all gene variants affect health and development?: MedlinePlus Genetics says a variant of uncertain significance cannot be confirmed to play a role in the development of disease, and there may not be enough scientific research to confirm or refute a disease association.
• Richards et al., ACMG/AMP Standards and Guidelines for the Interpretation of Sequence Variants, Genet Med 2015;17(5):405-424 (PMC4544753) (Terminology): ACMG/AMP say the terms mutation and polymorphism often lead to confusion due to incorrect assumptions of pathogenic and benign effects, and recommend both be replaced by the term variant with one of the five modifiers.
• National Society of Genetic Counselors: How Can Genetic Counselors Help Me Understand Results from Genetic Testing?: NSGC says genetic test results are often stated in various ways: positive, high risk, pathogenic, inconclusive, variants, mutations.
• MedlinePlus Genetics: Do all gene variants affect health and development?: MedlinePlus Genetics says a likely pathogenic variant is probably responsible for causing disease, but there is not enough scientific research to be certain.
• Richards et al., ACMG/AMP Standards and Guidelines for the Interpretation of Sequence Variants, Genet Med 2015;17(5):405-424 (PMC4544753) (Terminology): ACMG/AMP propose that likely pathogenic and likely benign be used to mean greater than 90% certainty of a variant being disease-causing or benign, to give laboratories a common, albeit arbitrary, definition, and note that at present most variants do not have data to support a quantitative assignment of certainty.
• CSER Consortium, Guide to Interpreting Genomic Reports: A Genomics Toolkit, hosted by NHGRI (Section 2, Key Points and text, printed pp. 8-9): The CSER toolkit says clinically both pathogenic and likely pathogenic variants are usually treated the same, as if they are likely disease causing.
• MedlinePlus Genetics: What are reduced penetrance and variable expressivity?: MedlinePlus Genetics says penetrance refers to the proportion of people with a particular genetic variant who exhibit signs and symptoms of a genetic disorder, and that if some people with the variant do not develop features of the disorder, the condition is said to have reduced (or incomplete) penetrance.
• MedlinePlus Genetics: What are reduced penetrance and variable expressivity?: MedlinePlus Genetics says reduced penetrance probably results from a combination of genetic, environmental and lifestyle factors, many of which are unknown.
• MedlinePlus Genetics: What are reduced penetrance and variable expressivity?: MedlinePlus Genetics says variable expressivity refers to the range of signs and symptoms that can occur in different people with the same genetic condition.
• Richards et al., ACMG/AMP Standards and Guidelines for the Interpretation of Sequence Variants, Genet Med 2015;17(5):405-424 (PMC4544753) (Special Considerations: Evaluating Variants in Healthy Individuals or as Incidental Findings): ACMG/AMP say caution must be exercised with variants in healthy or asymptomatic individuals or incidental findings, and that the predicted penetrance of pathogenic variants found in the absence of a phenotype or family history may be far less than predicted from historical data from patients ascertained with disease.
• MedlinePlus Genetics: What is a gene variant and how do variants occur?: MedlinePlus Genetics says inherited (hereditary) variants are passed from parent to child, are present throughout a person's life in virtually every cell in the body, and are also called germline variants because they are present in the parent's egg or sperm cells.
• MedlinePlus Genetics: What is a gene variant and how do variants occur?: MedlinePlus Genetics says non-inherited variants occur at some time during a person's life, are present only in certain cells, are often referred to as somatic variants, and cannot be passed to the next generation.
• MedlinePlus Genetics: What do the results of genetic tests mean?: MedlinePlus Genetics says that because family members have some genetic material in common, a positive test result may also have implications for certain blood relatives of the person tested.
• Stadler ZK et al., Universal Germline Genetic Testing after a Diagnosis of Cancer, Cancer Discov 2026 Oct 8, online ahead of print (PubMed abstract, PMID 42844684): The Cancer Discovery study (published online October 8, 2026; authors at Memorial Sloan Kettering) performed germline sequencing of 39,184 unselected patients with solid malignancies spanning 32 tumor types, looking at more than 90 cancer predisposition genes.
• Stadler ZK et al., Universal Germline Genetic Testing after a Diagnosis of Cancer, Cancer Discov 2026 Oct 8, online ahead of print (PubMed abstract, PMID 42844684): The study grouped patients as early-, average- or late-onset by standard deviations from the tumor-specific mean age at diagnosis and found pathogenic variant prevalence of 18.4% in early-onset, 15.6% in average-onset and 12.3% in late-onset tumors.
• Richards et al., ACMG/AMP Standards and Guidelines for the Interpretation of Sequence Variants, Genet Med 2015;17(5):405-424 (PMC4544753) (Reporting of Sequence Variants: Variant re-analysis): ACMG/AMP encourage laboratories to consider proactive amendment of cases when a variant reported with a near definitive classification (Pathogenic or Benign) must be reclassified.
• MedlinePlus Genetics: Do all gene variants affect health and development?: MedlinePlus Genetics says it is important to re-evaluate variants periodically, because the classification of a variant can change over time as more information becomes known through additional scientific research.
• CSER Consortium, Guide to Interpreting Genomic Reports: A Genomics Toolkit, hosted by NHGRI (Section 1, Limitations, printed p. 6): The CSER toolkit says it is highly likely that a reported genetic variant is truly present, particularly if the laboratory uses a second testing method such as Sanger sequencing to confirm it, but that a classification as pathogenic or likely pathogenic may be incorrect and emerging evidence may lead to reclassification.
• Richards et al., ACMG/AMP Standards and Guidelines for the Interpretation of Sequence Variants, Genet Med 2015;17(5):405-424 (PMC4544753) (Reporting of Sequence Variants: Confirmation of findings): ACMG/AMP say that, except as noted, confirmation studies using an orthogonal method are recommended for all sequence variants considered pathogenic or likely pathogenic for a Mendelian disorder.
• MedlinePlus Genetics: What should I know before proceeding with direct-to-consumer genetic testing?: MedlinePlus Genetics says standards and guidelines may differ between direct-to-consumer companies and companies that offer testing through a healthcare provider, so direct-to-consumer results typically need to be confirmed by additional testing ordered through a healthcare provider before they can be considered diagnostic and used to make medical decisions.
• National Society of Genetic Counselors: At-Home Genetic Testing: NSGC says at-home or direct-to-consumer tests are typically more limited than clinical testing ordered by doctors and genetic counselors, and don't follow the same guidelines as tests ordered through a doctor or genetic counselor.
• FDA: Direct-to-Consumer Tests (content current as of 12/20/2019): FDA says not all direct-to-consumer genetic test companies test for the same set of variants, and therefore may provide different results for the same disease or condition.
• FDA: Direct-to-Consumer Tests (content current as of 12/20/2019): FDA says genetic health risk tests do not determine a person's overall risk of developing a disease or condition, and that environmental, other genetic and lifestyle factors also contribute.
• Richards et al., ACMG/AMP Standards and Guidelines for the Interpretation of Sequence Variants, Genet Med 2015;17(5):405-424 (PMC4544753) (Special Considerations: Common Complex Disorders): ACMG/AMP say the terms pathogenic and likely pathogenic are not appropriate for risk alleles in common complex disorders even when the association is statistically valid, and suggest reporting them as risk alleles or under a separate other reportable category.
• NHGRI Talking Glossary: Genetic Counseling: NHGRI's glossary says a genetic counselor might provide information about how a genetic condition could affect an individual or family and/or interpret genetic tests designed to help estimate the risk of a disease.
• MedlinePlus Genetics: How can I find a genetics professional in my area?: MedlinePlus Genetics says the National Society of Genetic Counselors offers a searchable directory of genetic counselors in the United States and Canada.
• Richards et al., ACMG/AMP Standards and Guidelines for the Interpretation of Sequence Variants, Genet Med 2015;17(5):405-424 (PMC4544753) (Reporting of Sequence Variants: Interpretation): ACMG/AMP say a discussion of decreased penetrance and variable expressivity of the disorder, if relevant, should be included in the final report.
• MedlinePlus Genetics: What do the results of genetic tests mean?: MedlinePlus Genetics says that when interpreting test results, health care providers consider a person's medical history, family history and the type of genetic test that was done.

Start your 7-day free trialAllele is made by Triangle. 7-day free trial, then $9 a month. Cancel anytime.